A detailed history of Consilium Wealth Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Consilium Wealth Advisory, LLC holds 7,401 shares of ABBV stock, worth $1.33 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
7,401
Previous 2,000 270.05%
Holding current value
$1.33 Million
Previous $343,000 325.95%
% of portfolio
0.81%
Previous 0.19%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$163.84 - $199.33 $884,899 - $1.08 Million
5,401 Added 270.05%
7,401 $1.46 Million
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $201,533 - $229,628
-1,261 Reduced 38.67%
2,000 $364,000
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $579,158 - $652,268
-4,209 Reduced 56.35%
3,261 $505,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $381,265 - $441,371
2,854 Added 61.83%
7,470 $1.11 Million
Q2 2023

Jul 13, 2023

BUY
$132.51 - $164.9 $155,566 - $193,592
1,174 Added 34.11%
4,616 $621,000
Q1 2023

Apr 13, 2023

SELL
$144.61 - $166.54 $54,517 - $62,785
-377 Reduced 9.87%
3,442 $548,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $68,878 - $82,603
498 Added 15.0%
3,819 $617,000
Q3 2022

Oct 12, 2022

BUY
$134.21 - $153.93 $176,486 - $202,417
1,315 Added 65.55%
3,321 $446,000
Q2 2022

Jul 12, 2022

SELL
$137.62 - $174.96 $30,276 - $38,491
-220 Reduced 9.88%
2,006 $307,000
Q1 2022

Apr 18, 2022

BUY
$131.98 - $163.75 $29,827 - $37,007
226 Added 11.3%
2,226 $361,000
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $214,860 - $271,860
2,000 New
2,000 $271,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Consilium Wealth Advisory, LLC Portfolio

Follow Consilium Wealth Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consilium Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Consilium Wealth Advisory, LLC with notifications on news.